141 related articles for article (PubMed ID: 17987377)
1. Substitutions of three amino acids in human heart/muscle type carnitine palmitoyltransferase I caused by single nucleotide polymorphisms.
Yamazaki N; Matsuo T; Kurata M; Suzuki M; Fujiwaki T; Yamaguchi S; Terada H; Shinohara Y
Biochem Genet; 2008 Feb; 46(1-2):54-63. PubMed ID: 17987377
[TBL] [Abstract][Full Text] [Related]
2. Replacement of C305 in heart/muscle-type isozyme of human carnitine palmitoyltransferase I with aspartic acid and other amino acids.
Matsuo T; Yamamoto A; Yamamoto T; Otsuki K; Yamazaki N; Kataoka M; Terada H; Shinohara Y
Biochem Genet; 2010 Apr; 48(3-4):193-201. PubMed ID: 19937377
[TBL] [Abstract][Full Text] [Related]
3. Pig muscle carnitine palmitoyltransferase I (CPTI beta), with low Km for carnitine and low sensitivity to malonyl-CoA inhibition, has kinetic characteristics similar to those of the rat liver (CPTI alpha) enzyme.
Relat J; Nicot C; Gacias M; Woldegiorgis G; Marrero PF; Haro D
Biochemistry; 2004 Oct; 43(39):12686-91. PubMed ID: 15449958
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of highly expressed human heart muscle carnitine palmitoyltransferase I.
Zhu H; Shi J; Cregg JM; Woldegiorgis G
Biochem Biophys Res Commun; 1997 Oct; 239(2):498-502. PubMed ID: 9344859
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.
Corti S; Bordoni A; Ronchi D; Musumeci O; Aguennouz M; Toscano A; Lamperti C; Bresolin N; Comi GP
J Neurol Sci; 2008 Mar; 266(1-2):97-103. PubMed ID: 17936304
[TBL] [Abstract][Full Text] [Related]
6. Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency.
Isackson PJ; Bennett MJ; Vladutiu GD
Mol Genet Metab; 2006 Dec; 89(4):323-31. PubMed ID: 16996287
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency.
IJlst L; Mandel H; Oostheim W; Ruiter JP; Gutman A; Wanders RJ
J Clin Invest; 1998 Aug; 102(3):527-31. PubMed ID: 9691089
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency.
Bennett MJ; Boriack RL; Narayan S; Rutledge SL; Raff ML
Mol Genet Metab; 2004 May; 82(1):59-63. PubMed ID: 15110323
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
10. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
[TBL] [Abstract][Full Text] [Related]
11. Interrelation between long-chain fatty acid oxidation rate and carnitine palmitoyltransferase 1 activity with different isoforms in rat tissues.
Doh KO; Kim YW; Park SY; Lee SK; Park JS; Kim JY
Life Sci; 2005 Jun; 77(4):435-43. PubMed ID: 15894012
[TBL] [Abstract][Full Text] [Related]
12. Carnitine palmitoyltransferase deficiencies.
Bonnefont JP; Demaugre F; Prip-Buus C; Saudubray JM; Brivet M; Abadi N; Thuillier L
Mol Genet Metab; 1999 Dec; 68(4):424-40. PubMed ID: 10607472
[TBL] [Abstract][Full Text] [Related]
13. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
[TBL] [Abstract][Full Text] [Related]
14. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation identified in carnitine palmitoyltransferase II deficiency.
Yang BZ; Ding JH; Roe D; Dewese T; Day DW; Roe CR
Mol Genet Metab; 1998 Feb; 63(2):110-5. PubMed ID: 9562964
[TBL] [Abstract][Full Text] [Related]
16. [Identification of muscle-type carnitine palmitoyltransferase I and characterization of its gene structure].
Yamazaki N
Yakugaku Zasshi; 2004 Dec; 124(12):893-908. PubMed ID: 15577262
[TBL] [Abstract][Full Text] [Related]
17. Regulation of fatty acid oxidation in chicken (Gallus gallus): interactions between genotype and diet composition.
Collin A; Swennen Q; Skiba-Cassy S; Buyse J; Chartrin P; Le Bihan-Duval E; Crochet S; Duclos MJ; Joubert R; Decuypere E; Tesseraud S
Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):171-7. PubMed ID: 19258045
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of two mutations in carnitine palmitoyltransferase IA deficiency.
Ogawa E; Kanazawa M; Yamamoto S; Ohtsuka S; Ogawa A; Ohtake A; Takayanagi M; Kohno Y
J Hum Genet; 2002; 47(7):342-7. PubMed ID: 12111367
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of SNPs and enzymatic disorder in the patients of influenza-associated encephalopathy: disorder of fatty acid metabolism in mitochondria induced by high fever].
Kido H; Yao D; Le Trong Q; Tsukane M; Chida J
Nihon Rinsho; 2006 Oct; 64(10):1879-86. PubMed ID: 17037363
[TBL] [Abstract][Full Text] [Related]
20. [Mitochondrial beta-oxidation defects].
Woldseth B; Rootwelt T
Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
